Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

lexaria bioscience

POPULAR ARTICLES

Lexaria Updates Financial Position

biotech investing

Lexaria Updates Financial Position

Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds

biotech investing

Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds

Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds

biotech investing

Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds

LATEST ARTICLES

Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference

biotech investing

Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Lexaria Receives USD$2.6 Million Tax Rebate Payment

biotech investing

Lexaria Receives USD$2.6 Million Tax Rebate Payment

DehydraTECH-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2

biotech investing

DehydraTECH-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2

DehydraTECH-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2

biotech investing

DehydraTECH-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2

Lexaria Enters a Material Transfer Agreement With PegBio

biotech investing

Lexaria Enters a Material Transfer Agreement With PegBio

Lexaria Updates Business Development

biotech investing

Lexaria Updates Business Development

Lexaria Updates Business Development

biotech investing

Lexaria Updates Business Development

Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule

biotech investing

Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule

Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule

biotech investing

Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule

GLP-1 "Arms Race" Intensifies as the Addressable Markets Continue to Expand

biotech investing

GLP-1 "Arms Race" Intensifies as the Addressable Markets Continue to Expand

GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand

biotech investing

GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand

Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway

biotech investing

Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway

Latest News

Brixton Metals Announces Closing of Final Tranche of Non-Brokered Private Placement

Canadian Investment Regulatory Organization Trade Resumption - TDG

One Bullion Advances Maitengwe Gold Project Toward Field Verification and Planned Drill Testing

Cerrado Gold Acquires the Past-Producing Manantial Espejo Mine in Santa Cruz, Argentina, from Pan American Silver

Triumph Gold Announces Strategic Review of Non-Core Exploration Projects and $15 Million Private Placement

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Ucore Rare Metals

Ucore Rare Metals (UCU:CC)

Silver Hammer Mining

Silver Hammer Mining (HAMR:CC)

Lahontan Gold Corp.

Lahontan Gold Corp. (LG:CC)

CoTec Holdings

CoTec Holdings (CTH:CC)

The Calmer Co

The Calmer Co (CCO:AU)

Brixton Metals

Brixton Metals (BBB:CC)

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES